Evidence map›Paper›PMID 40516152›Full record

ArticleOral oncology2025

Computed tomography radiomics-based cross-sectional detection of mandibular osteoradionecrosis in head and neck cancer survivors.

Serageldin Kamel, Laia Humbert-Vidan, Zaphanlene Kaffey, Sarah Mirbahaeddin, Abdulrahman Abusaif, David T A Fuentes, Kareem Wahid, Cem Dede, Mohamed A Naser, Renjie He and 16 more

Abstract read
In one paragraph

Article in Oral oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

26 authors.

Serageldin KamelThe University of Texas MD Anderson Cancer Center, Department of Radiation Oncology, Houston, USA.
Laia Humbert-VidanThe University of Texas MD Anderson Cancer Center, Department of Radiation Oncology, Houston, USA.
Zaphanlene KaffeyThe University of Texas MD Anderson Cancer Center, Department of Radiation Oncology, Houston, USA.
Sarah MirbahaeddinThe University of Texas MD Anderson Cancer Center, Department of Radiation Oncology, Houston, USA.
Abdulrahman AbusaifThe University of Texas MD Anderson Cancer Center, Department of Radiation Oncology, Houston, USA.
David T A FuentesThe University of Texas MD Anderson Cancer Center, Department of Imaging Physics, Houston, USA.
Kareem WahidThe University of Texas MD Anderson Cancer Center, Department of Radiation Oncology, Houston, USA; The University of Texas MD Anderson Cancer Center, Department of Imaging Physics, Houston, USA.
Cem DedeThe University of Texas MD Anderson Cancer Center, Department of Radiation Oncology, Houston, USA.
Mohamed A NaserThe University of Texas MD Anderson Cancer Center, Department of Radiation Oncology, Houston, USA.
Renjie HeThe University of Texas MD Anderson Cancer Center, Department of Radiation Oncology, Houston, USA.
Ahmed W MoawadThe University of Texas MD Anderson Cancer Center, Department of Radiology, Houston, USA.
Khaled M ElsayesThe University of Texas MD Anderson Cancer Center, Department of Radiology, Houston, USA.
Melissa M ChenThe University of Texas MD Anderson Cancer Center, Department of Radiology, Houston, USA.
Adegbenga O OtunThe University of Texas MD Anderson Cancer Center, Department of Head and Neck Surgery, Houston, USA.
Jillian RigertThe University of Texas MD Anderson Cancer Center, Department of Radiation Oncology, Houston, USA.
Mark S ChambersThe University of Texas MD Anderson Cancer Center, Department of Head and Neck Surgery, Houston, USA.
Andrew HopeDepartment of Radiation Oncology, Princess Margaret Cancer Centre, Toronto, Canada.
Erin WatsonDepartment of Radiation Oncology, Princess Margaret Cancer Centre, Toronto, Canada; Faculty of Dentistry, University of Toronto, Toronto, Canada.
Kristy K BrockThe University of Texas MD Anderson Cancer Center, Department of Imaging Physics, Houston, USA.
Katherine HutchesonThe University of Texas MD Anderson Cancer Center, Department of Head and Neck Surgery, Houston, USA.
Lisanne van DijkDepartment of Radiation Oncology, University Medical Center Groningen, the Netherlands.
Amy C MorenoThe University of Texas MD Anderson Cancer Center, Department of Radiation Oncology, Houston, USA.
Stephen Y LaiThe University of Texas MD Anderson Cancer Center, Department of Radiation Oncology, Houston, USA; The University of Texas MD Anderson Cancer Center, Department of Head and Neck Surgery, Houston, USA. Electronic address: sylai@mdanderson.org.
Clifton D FullerThe University of Texas MD Anderson Cancer Center, Department of Radiation Oncology, Houston, USA. Electronic address: cdfuller@mdanderson.org.
Abdallah S R MohamedThe University of Texas MD Anderson Cancer Center, Department of Radiation Oncology, Houston, USA; Department of Radiation Oncology, Baylor College of Medicine, Houston, USA. Electronic address: ASMohamed@mdanderson.org.
MD Anderson Head and Neck Cancer Symptom Working Group

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
Paul Calabresi Clinical Oncology AwardK12CA088084 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI David S. Hong, Scott Kopetz · 2000 to 2026
$14.0M
Early Detection of Hepatocellular CarcinomaR01CA195524 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI LAURA BERETTA, David Fuentes · 2016 to 2026
$6.5M
Development of functional magnetic resonance imaging-guided adaptive radiotherapy for head and neck cancer patients using novel MR-Linac deviceR01DE028290 · NIDCR · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI CHRISTODOULEAS, JOHN PAUL, FULLER, CLIFTON DAVID · 2019 to 2023
$4.3M
Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) to Establish Objective Clinical Outcome Measures for Mandibular OsteoradionecrosisR01DE025248 · NIDCR · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI LAI, STEPHEN Y · 2016 to 2020
$2.9M
Longitudinal Spatial-Nonspatial Decision Support for Competing Outcomes in Head and Neck Cancer TherapyR01CA258827 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI CANAHUATE, GUADALUPE, FULLER, CLIFTON DAVID · 2021 to 2025
$2.9M
Quantitative Imaging Biomarker Prospective Validation of Dynamic Contrast-Enhanced MRI as a Metric of Orodental Injury After Radiotherapy (QI-ProVE-MRI)U01DE032168 · NIDCR · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Clifton David Fuller, STEPHEN Y LAI · 2023 to 2026
$2.8M
SCH: Personalized Rescheduling of Adaptive Radiation Therapy for Head & Neck CancerR01CA257814 · NCI · RICE UNIVERSITY · PI FULLER, CLIFTON DAVID, SCHAEFER, ANDREW J · 2021 to 2024
$1.8M
Ontology-based aPplications of mUlti-discipLinary knowlEdge on orodeNtal Conditions and outcomEs (OPULENCE)R01DE034406 · NIDCR · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Amy Catherine Moreno · 2025 to 2026
$1.5M
Image Guided Cancer Therapy Training ProgramT32CA261856 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Kristy Brock, Clifton David Fuller · 2022 to 2026
$1.2M
Probabilistic Deep Learning Cervical Lymph-Node Auto-Segmentation For Imaging-enhanced Evaluation of Extracapsular Extension Risk (PDL-CLASIFIER)R03DE033550 · NIDCR · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI FULLER, CLIFTON DAVID, NASER, MOHAMED · 2024 to 2025
$499k
Provider and Patient-generated Remote Oro-Dental Health Electronic Data Capture for Algorithmic Longitudinal Evaluation and Risk-Assessment (PROHEALER)K01DE030524 · NIDCR · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI MORENO, AMY CATHERINE · 2022 to 2024
$479k
NCI NIH HHS K12 CA088084NCI NIH HHS P30 CA016672NCI NIH HHS R01 CA195524NCI NIH HHS R01 CA257814NCI NIH HHS R01 CA258827NCI NIH HHS T32 CA261856NIDCR NIH HHS F31 DE031502NIDCR NIH HHS K01 DE030524NIDCR NIH HHS R01 DE025248NIDCR NIH HHS R01 DE028290NIDCR NIH HHS R01 DE034406NIDCR NIH HHS R03 DE033550NIDCR NIH HHS R21 DE031082NIDCR NIH HHS U01 DE032168
6 · The paper itself

Abstract

purposeThis study aims to identify radiomic features from contrast-enhanced CT (CECT) scans that differentiate osteoradionecrosis (ORN) from normal mandibular bone in head and neck cancer (HNC) patients treated with radiotherapy (RT). MATERIALS AND

methodsCECT images from 150 patients with confirmed ORN diagnosis (2008-2018) at MD Anderson Cancer Center (MDACC) were analyzed (80 % train, 20 % test). Radiomic features were extracted using PyRadiomics from manually segmented ORN regions and automated contralateral healthy mandible regions. Correlation analysis (r > 0.95) reduced features for model training. A random Forest (RF) classifier with Recursive Feature Elimination identified discriminative features. Explainability was assessed using SHapley Additive exPlanations (SHAP) analysis on the 20 most important features identified by the trained RF classifier.

resultsOf the 1316 radiomic features extracted, 810 features were excluded for high collinearity. From a set of 506 pre-selected radiomic features, 67 were optimal for RF classification, yielding 88% accuracy and a ROC AUC of 0.96. The model well calibrated (Log Loss 0.296, ECE 0.125) and achieved an accuracy of 88% and a ROC AUC of 0.96. The SHAP analysis revealed that higher values of Wavelet-LLH First order Mean and Median were associated with ORN of the jaw (ORNJ). Conversely, higher Exponential GLDM Dependence Entropy and lower Square First-order Kurtosis were more characteristic of normal mandibular tissue.

conclusionThis study successfully developed a CECT-based radiomics model for differentiating ORNJ from healthy mandibular tissue in HNC patients after RT. Future work will focus on detecting subclinical ORNJ regions to guide earlier interventions.

Indexed as

Head and Neck NeoplasmsMandibleMandibular DiseasesOsteoradionecrosisTomography, X-Ray ComputedAdultAgedCancer SurvivorsCross-Sectional StudiesFemaleHumansMaleMiddle AgedRadiomics

Identifiers

PMID40516152
PMCPMC12276996

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.